A new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal ...

CHENNAI: After a nine-year-old boy from Thirvur in Tiruvallur district died due to Guillain-Barre Syndrome (GBS) — a rare ...

ONAPGOis the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced Parkinson’s ...

The Food and Drug Administration (FDA) is hoping a newly approved non-opioid pain medication could help save lives. Dr.

Experts with the Cleveland Clinic say the drug has a lot of potential, especially since it is considered nonaddictive.

The U.S. Food and Drug Administration (FDA) approved suzetrigine under the brand name Journavx on Jan. 30, 2025. Journavx is a first-in-class non-opioid painkiller that acts on sodium channels in the ...

The Food and Drug Administration announced Thursday its approval of suzetrigine, the first new painkiller greenlit by the ...

FDA approves non-opioid pain reliever, suzetrigine, by Vertex Pharmaceuticals to mitigate risks of opioids and provide patients with more options.

The nervous system is a complex network of neurons and ... Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around 4 in every 10 patients ...

The human nervous system is defined as two parts. They are the central nervous system (CNS) and the peripheral nervous system (PNS). The CNS is located in the skull and vertebral canal of the spine.

Market Snapshot Stock-market investors are getting nervous about this bond-market move that’s only happened twice in over 40 years Only twice since the early 1980s has the 10-year yield jumped ...

The four-repeat (4R) tau pathology was recently identified in the peripheral nervous system of patients with progressive supranuclear palsy. Consequently, a 4R tau seeding assay using skin tissue from ...